Zenas Biopharma (ZBIO) versus Its Peers Financial Review

Zenas Biopharma (NASDAQ:ZBIO – Get Free Report) is one of 422 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Zenas Biopharma to similar companies based on the strength of its earnings, profitability, dividends, risk, analyst recommendations, institutional ownership and valuation. Institutional & Insider Ownership 29.3% of […]